Assessment of serum antioxidant levels in oral and oropharyngeal carcinoma patients

Vadisha Srinivas Bhat, Keerthan Ranga Nayak, Sanjay Kini, Satheesh Kumar Bhandary B, Suchetha Kumari N, Shubha P Bhat


Oral cavity and the oropharynx are the two most common sites of cancer in the head and neck region. The exposure of mucosal surface of the oral cavity and entire oropharynx to alcohol and tobacco-related carcinogens increases the risk for developing premalignant or malignant lesions. The purpose of this study is to assess the serum levels of total antioxidant capacity, vitamin C and malondialdehyde in confirmed cases of oral and oropharyngeal squamous cell carcinoma and their correlation in healthy subjects.


Bhat VS, Nayak KR, Kini S, Bhandary SK, Kumari S, Bhat SP. IJPLM. 2016;2(1):OA1 (Republished: 22 December 2016)


Oral carcinoma; Oropharyngeal carcinoma; Total antioxidant capacity; Vitamin C; Malondialdehyde


1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics. CA Cancer J Clin 2010; 60:277-300.

2. Gupta PC, Nandakumar A. Oral cancer scene in India. Oral Dis 1999; 5:1-2.

3. Blot WJ, McLaughlin JK, Devesa SS, Fraumeni JF Jr. Cancers of the oral cavity and pharynx. In: Schottenfeld D, Fraumeni JF, eds. Cancer Epidemiology and Prevention. 2nd ed. New York: Oxford University Press 1996; 666-80.

4. Raghuwanshi U, Choudhari SC, Patil R. Serum α-tocopherol levels indicating status of oral carcinoma patients. Int J Health Sci Res. 2012;2(9):60-64.

5. Marakala V, Malathi M, Shivashankara AR. Lipid Peroxidation and Antioxidant Vitamin Status in Oral Cavity and Oropharyngeal Cancer Patients. Asian Pacific J Cancer Prev;13 (11), 5763-5765.

6. Freeman BA, Crapo JD. Biology of disease: free radicals and tissue injury. Lab. Invest1982;47: 412-426

7. Sibille Y, Reynolds HY. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am. Rev. Respir. Dis. 1990; 141: 471-501.

8. Crystal RG. Oxidants and respiratory tract epithelial injury: pathogenesis and strategies for therapeutic intervention. Am J Med 1991; 91: 39S-44S,

9. Kamp DW, Graceffa P, Pryor WA, and Weitzman SA. The role of free radicals in asbestos- induced diseases. Free Radic. Biol. Med 1992; 12: 293-315

10. Kolanjiappan K, Ramachandran CR, Manoharan S. Biochemical changes in tumor tissues of oral cancer patients. ClinBiochem 2003; 36: 61–5.

11. Abidi S, Ali A. Role of oxygen free radicals in the pathogenesis and etiology of cancer. Cancer Lett 1999; 142 : 1-9.

12. Noguchi N, Watanabe A, Shi H. Diverse functions of antioxidants. Free radical research 2000;33(6): 809-17.

13. Figuero E, Soory M, Cerero R, Bascones A. Oxidant/antioxidant interactions of nicotine, Coenzyme Q10, Pycnogenol and phytoestrogens in oral periosteal fibroblasts and MG63 osteoblasts. Steroids. 2006;71(13-14):1062-1072.

14. Simon JA, Hudes ES and JA Tice. Relation of Serum Ascorbic Acid to Mortality among US Adults. J Am Col Nutr 2001; 20(3):255-63

15. Block G. Epidemiological Evidence Regarding Vitamin C and Cancer. Am J Clin Nutr 1999; 54 (6): 1305-14.

16. Aparna R, Bitla E, Prabhakar Reddy, Sambasivaih K, Suchitra MM, Seshadri Reddy V, Srinivasa Rao PVLN. Evaluation of plasma malondialdehyde as a biomarker in patients with carcinoma of stomach. Biomedical Research 2011; 22(1):63-68.

17. IARC monographs on the evaluation of carcinogenic risks to humans. Tobacco smoke and involuatary smoking. lyon (France): IARC 2004;83:1452.

18. Ramya R, Prakash S, Sudha S. Assessment of serum malondialdehyde in oral squamous cell carcinoma patients and its association with tobacco habits. JPBMS 2011;10(16):1-3.

19. Prieto, Manuel, P. and Miguel, A. Spectrophotometric quantitation of antioxidant capacity through the formation of phosphomolybdenum complex: specific application to the determination of vitamin E. Analytical biochemistry 1999; 259: 337-41.

20. Buege, JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978;52: 302-10.

21. Castelli A, Martorana GE, Frasea AM and Meucci E. Colorimetric detection of plasma vitamin C: comparison between 2,4-Di nitrophenyl hydrazine and phosphotu+ngstic acid methods. ActaVitaminol Enzymol 1981;3(2): 103-10.

22. Patel MM and Pandya AN. Relationship of oral cancer with age, sex, site distribution and habits. Indian J Pathol Microbiol 2004; 47(2): 195-197.

23. Bhat SP, Naik RCN, GK Swetadri, D’souza H, Jayaprakash CS, Bhat V. Clinicopathological Spectrum Of Malignancies Of Oral Cavity And Oropharynx.

24. Iype EM, Pandey M, Mathew A, Thomas G, Sebastian P, Nair MK. Oral cancer among patients under the age of 35 years. J Postgrad Med. 2001;47(3):171-6.

25. Durazzo MD, de Araujo CE, Brandão Neto Jde S, Potenza Ade S, Costa P, Takeda F, Bianchi C, Tavares MR, de Britto e Silva Filho G, Ferraz AR. Clinical and epidemiological features of oral cancer in a medical school teaching hospital from 1994 to 2002: increasing incidence in women, predominance of advanced local disease, and low incidence of neck metastases. Clinics (Sao Paulo) 2005;60(4):293-8.

26. Korde SD, Basak A, Chaudhary M, Goyal M, Vagga A. Enhanced nitrosative and oxidative stress with decreased total antioxidant capacity in patients with oral precancer and oral squamous cell carcinoma. Oncology 2011;80(5-6):382-9.

27. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants and the degenerative diseases of aging. Proc Natl Acad Sci U S A 1993; 90(17): 7915–7922.

28. Premkumar P, Bharathan S, Nagini S. Oxidant antioxidant status in patients with oral squamous cell carcinoma in tissue and plasma. Asian J Exp Biol Sci 2011; 2(2): 316-327.

29. Malathi M, Vijaya M, Shivashankara AR. The role of oxidative stress and the effect of radiotherapy on the plasma oxidant-antioxidant status in head and neck cancer. Journal Of Clinical And Diagnostic Research. 2011;5(2):249-251.

30. Chole RH, Patil RN, Basak A, Palandurkar K, Bhowate R. Estimation of serum malondialdehyde in oral cancer and precancer and its association with healthy individuals, gender, alcohol, and tobacco abuse. J Can Res Ther 2010;6:487-91.

31. Patait MR, Mody RN. Estimation of serum malondialdehyde before and after radiotherapy in oral squamous cell carcinoma patients undergoing antioxidant therapy. JIAOMR 2011;23(4):56;23(4):563-568.